Schmidt V A, Nierman W C, Maglott D R, Cupit L D, Moskowitz K A, Wainer J A, Bahou W F
Department of Medicine, State University of New York at Stony Brook, Stony Brook, New York 11794, USA.
J Biol Chem. 1998 Jun 12;273(24):15061-8. doi: 10.1074/jbc.273.24.15061.
Proteolytically activated receptors (PARs) represent an emerging subset of seven transmembrane G protein-coupled receptors that mediate cell activation events by receptor cleavage at distinct scissile bonds located within receptor amino termini. Differential genomic blotting using a yeast artificial chromosome known to contain the PAR-1 and PAR-2 genes identified the PAR-3 gene within a PAR gene cluster spanning approximately 100 kilobases at 5q13. The PAR-3 gene is relatively small (approximately 12 kilobases); and, like the PAR-1 and PAR-2 genes, it displays a two-exon structure, with the majority of the coding sequence and the proteolytic cleavage site contained within the larger second exon. Sequence analysis of the 5'-flanking region demonstrates that the promoter is TATA-less, similar to that seen with PAR-1, with the identification of nucleic acid motifs potentially involved in transcriptional gene regulation, including AP-1, GATA, and octameric sequences. PAR-3 transcripts were apparent in human vascular endothelial cells, although at considerably lower levels than those of PAR-1 and not significantly modulated by the endothelial cell stimulus tumor necrosis factor-alpha. Likewise, although PAR-3 mRNA was evident in human platelets, receptor cell surface expression was modest (approximately 10%) compared with that of PAR-1. Thus, although PAR-3 is postulated to represent a second thrombin receptor, its modest endothelial cell and platelet expression suggest that PAR-3 activation by alpha-thrombin is less relevant for physiological responses in these mature cells. Rather, given its disparately greater expression in megakaryocytes (and megakaryocyte-like human erythroleukemia cells), a regulatory role in cellular development (by protease activation) could be postulated.
蛋白酶激活受体(PARs)是七跨膜G蛋白偶联受体中新兴的一个亚群,通过位于受体氨基末端不同可裂解键处的受体裂解来介导细胞激活事件。使用已知包含PAR-1和PAR-2基因的酵母人工染色体进行差异基因组印迹分析,在位于5q13的一个跨度约100千碱基的PAR基因簇中鉴定出PAR-3基因。PAR-3基因相对较小(约12千碱基);并且,与PAR-1和PAR-2基因一样,它呈现出双外显子结构,大部分编码序列和蛋白水解切割位点包含在较大的第二个外显子中。对5'侧翼区域的序列分析表明,其启动子无TATA盒,与PAR-1类似,同时鉴定出了可能参与转录基因调控的核酸基序,包括AP-1、GATA和八聚体序列。PAR-3转录本在人血管内皮细胞中明显存在,尽管其水平远低于PAR-1,且不受内皮细胞刺激物肿瘤坏死因子-α的显著调节。同样,虽然PAR-3 mRNA在人血小板中明显存在,但与PAR-1相比,受体在细胞表面的表达水平较低(约10%)。因此,尽管推测PAR-3代表第二种凝血酶受体,但其在内皮细胞和血小板中的适度表达表明,α-凝血酶对PAR-3的激活在这些成熟细胞的生理反应中不太相关。相反,鉴于其在巨核细胞(以及类巨核细胞的人红白血病细胞)中表达明显更高,可以推测其在细胞发育中具有通过蛋白酶激活的调节作用。